Atrium Therapeutics, Inc. (RNA)
8.25
-0.15
(-1.79%)
USD |
NASDAQ |
Oct 29, 16:00
8.25
0.00 (0.00%)
After-Hours: 20:00
Atrium Therapeutics Market Cap : 141.12M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 143.69M |
| October 27, 2026 | 142.32M |
| October 26, 2026 | 137.70M |
| October 23, 2026 | 140.27M |
| October 22, 2026 | 139.58M |
| October 21, 2026 | 136.85M |
| October 20, 2026 | 136.51M |
| October 19, 2026 | 130.18M |
| October 16, 2026 | 131.20M |
| October 15, 2026 | 133.77M |
| October 14, 2026 | 131.37M |
| October 13, 2026 | 132.57M |
| October 12, 2026 | 140.44M |
| October 09, 2026 | 143.69M |
| October 08, 2026 | 141.30M |
| October 07, 2026 | 135.65M |
| October 06, 2026 | 136.68M |
| October 05, 2026 | 136.33M |
| October 02, 2026 | 134.11M |
| October 01, 2026 | 139.24M |
| September 30, 2026 | 141.64M |
| September 29, 2026 | 144.03M |
| September 28, 2026 | 144.03M |
| September 25, 2026 | 141.81M |
| September 24, 2026 | 140.10M |
| Date | Value |
|---|---|
| September 23, 2026 | 142.49M |
| September 22, 2026 | 157.72M |
| September 21, 2026 | 157.20M |
| September 18, 2026 | 153.10M |
| September 17, 2026 | 163.53M |
| September 16, 2026 | 162.51M |
| September 15, 2026 | 172.60M |
| September 14, 2026 | 174.65M |
| September 11, 2026 | 177.22M |
| September 10, 2026 | 177.05M |
| September 09, 2026 | 179.78M |
| September 08, 2026 | 194.15M |
| September 04, 2026 | 242.73M |
| September 03, 2026 | 249.75M |
| September 02, 2026 | 240.51M |
| September 01, 2026 | 235.55M |
| August 31, 2026 | 227.85M |
| August 28, 2026 | 233.33M |
| August 27, 2026 | 239.14M |
| August 26, 2026 | 236.92M |
| August 25, 2026 | 239.48M |
| August 24, 2026 | 232.98M |
| August 21, 2026 | 225.80M |
| August 20, 2026 | 230.59M |
| August 19, 2026 | 234.52M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Tenax Therapeutics, Inc. | 59.59M |
| Exicure, Inc. | 5.991M |
| Century Therapeutics, Inc. | 262.70M |
| Absci Corp. | 2.076B |
| Celularity, Inc. | 24.60M |
Market Cap Related Metrics
| PS Ratio | 5.161 |
| PEG Ratio | -0.0057 |
| Price to Book Value | 0.6576 |
| Price | 8.25 |
| Earnings Yield | -55.85% |
| PEGY Ratio | -0.0057 |